Differential response of patient-derived primary glioblastoma cells to metabolic and adhesion inhibitors
Rasha Rezk, Fikret Basar, John Mediavillo, Rebecca Donaldson, Colin Watts, Kristian Franze, Alexandre Kabla
This study examines how patient-derived glioblastoma cells from different tumor regions respond to adhesion and metabolic inhibitors, showing heterogeneity in drug sensitivity linked to migration and adhesion properties.
Clinical and Experimental Medicine · Jun 26, 2025Peer-reviewedNeuroscience